Changes in gene expression with increased transglutaminase 2 in a SH-SY5Y cell line

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 2, 2006, Pages 2774-2781

  Lee, Ju Seog ^a   Kim, In Hoo ^b   Kim, Soo Youl ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b National Cancer Center   (South Korea)

^c NONE   (South Korea)

Author keywords

Inflammation; Microarray; Neuroblastoma; NF B; SH SY5Y; Transglutaminase 2

Indexed keywords

EID: 33744484008     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2007     Document Type: Article

References (44)

1. J.E. Folk & S.-I. Chung: Transglutaminases. Methods in Enzymol. 113, 358-375 (1985)
2. V.A. Thomazy & P.J. Davies: Expression of tissue transglutaminase in the developing chicken limb is associated both with apoptosis and endochondral ossification. Cell Death Differ. 6, 146-154 (1999)
3. D. Aeschlimann & V. Thomazy: Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect. Tissue Res. 41, 1-27 (2000)
4. S.-Y. Kim, T.M. Jeitner & P.M. Steinert Transglutaminases in disease. Neurochem. Int. 40, 85-103 (2002)
5. K.-C. Park, K.-C., Chung, Y.-S. Kim, J. Lee, T.-H. Joh & S.-Y. Kim: Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia. Biochem. Biophys. Res. Commun. 323, 1055-1062 (2004)
6. J. Lee, Y.-S. Kim, D.-H. Choi, M.-S. Bang, T.-R. Han, T.-H. Joh & S.-Y. Kim: Transglutaminase 2 induces nuclear factor-κB activation via a novel pathway in BV-2 microglia. J. Biol. Chem. 279, 53725-53735 (2004)
7. V. Tergaonkar, V. Bottero, M. Ikawa, Q. Li & I.M. Verma: I-κB kinase-independent I-κBα degradation pathway: functional NF-κB activity and implications for cancer therapy. Mol Cell Biol. 23, 8070-8083 (2003)
8. 2+ increase. Biochem. Biophys. Res. Commun. 337, 655-662 (2005)
9. M. Karin & F.R. Greten: NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759 (2005)
10. J.-S. Lee, I.S. Chu, J. Heo, D.F. Calvisi, Z. Sun, T. Roskams, A. Durnez, A.J. Demetris & S.S. Thorgeirsson: Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40, 667-676 (2004)a
11. J.-S. Lee, I.S. Chu, A. Mikaelyan, D.F. Calvisi, J. Heo, J.K. Reddy & S.S. Thorgeirsson: Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat. Genet. 36, 1306-1311 (2004)b
12. C. Benou, Y. Wang, J. Imitola, L. VanVlerken, C. Chandras, K.P. Karalis & S.J. Khoury: Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. J. Immunol. 174, 5407-5413 (2005)
13. I.J. Wajda, H. Waelsch & J.M. Lee: Transglutaminase and experimental allergic encephalomyelitis. Life Sci. 4, 1853-1858 (1965)
14. H.M. Frankish, S. Dryden, D. Hopkins, Q. Wang & G. Williams: Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism. Peptides 16, 757-771 (1995)
15. J. Liu, J. Li, N. Zhai, L. Geng & F. Song: Detection of the levels of neuropeptides, ACTH and cortisol in the blood of patients with polymyositis/dermatomyositis and their significance. J. Dermatol. 31, 392-397 (2004)
16. Y.-C. Choi, G.-T. Park, T.-S. Kim, I.-N. Sunwoo, P.M. Steinert & S.-Y. Kim: Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2. J. Biol. Chem. 275, 8703-8710 (2000)
17. M. Delgado: Inhibition of interferon (IFN) γ-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression. J. Biol. Chem. 278, 27620-27629 (2003)
18. D.A. Walsh, J. Wharton, D.R. Blake & J.M. Polak: Neural and endothelial regulatory peptides, their possible involvement in inflammation. Int. J. Tiss. React. 14, 101-111 (1992)
19. C. Pincelli, F. Fantini & A. Giannetti: Neuropeptides and skin inflammation. Dermatology 187, 153-158 (1993)
20. J. Chan, B.R. Smoller, S.P. Raychauduri, W. Jiang & E.M. Farber: Intraepidermal nerve fiber expression of CGRP, VIP and substance P in psoriasis. Arch. Dermatol. Res. 289, 611-616 (1997)
21. K.A. Matkowskyj, A. Danilkovich, J. Marrero, S.D. Savkovic, G. Hecht & R.V. Benya: Galanin-1 receptor upregulation mediates the excess colonic fluid production caused by infection with enteric pathogens. Nat. Med. 6, 1048-1051 (2000)
22. T.A. Zimmers, X. Jin, E.C. Hsiao, S.A. McGrath, A.F. Esquela & L.G. Koniaris: Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 23, 543-548 (2005)
23. M. Wu, L.G. Xu, Z. Zhai & H.B. Shu: SINK is a p65-interacting negative regulator of NF-kappaB-dependent transcription. J. Biol. Chem. 278, 27072-27079 (2003)
24. K. Du, S. Herzig, R.N. Kulkarni & M. Montminy: TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300, 1574-1577 (2003)
25. S.K. Kang, J.Y. Lee, T.W. Chung & C.H. Kim: Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway. FEBS Lett. 577, 361-366 (2004)
26. E.F. Farias, C. Marzan & R. Mira-y-Lopez: Cellular retinol-binding protein-I inhibits PI3K/Akt signaling through a retinoic acid receptor-dependent mechanism that regulates p85-p110 heterodimerization. Oncogene 24, 1598-1606 (2005)
27. V. Neaud, J.G. Duplantier, C. Mazzocco, W. Kisiel & J. Rosenbaum: Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism. J. Biol. Chem. 279, 5200-5206 (2004)
28. A. Okado-Matsumoto, A. Matsumoto, J. Fujii & N. Taniguchi: Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J. Biochem. (Tokyo) 127, 493-501 (2000)
29. D.Y. Jin, H.Z. Chae, S.G. Rhee & K.T. Jeang: Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J. Biol. Chem. 272, 30952-30961 (1997)
30. H.M. Abu-Soud & S.L. Hazen: Nitric oxide is a physiological substrate for mammalian peroxidases. J. Biol. Chem. 275, 37524-37532 (2000)
31. D.W. Eib & G.J. Martens: A novel transmembrane protein with epidermal growth factor and follistatin domains expressed in the hypothalamo-hypophysial axis of Xenopus laevis. J. Neurochem. 67, 1047-1055 (1996)
32. H. Lin, K. Wada, M. Yonezawa, K. Shinoki, T. Akamatsu, T. Tsukui & C. Sakamoto: Tomoregulin ectodomain shedding by proinflammatory cytokines. Life Sci. 73, 1617-1627 (2003)
33. G.D. Watts, M. Thorne, M.J. Kovach, A. Pestronk & V.E. Kimonis: Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes. Neuromuscul. Disord. 13, 559-567 (2003)
34. F.M. Santorelli, M. Sciacco, K. Tanji, S. Shanske, T.H. Vu, V. Golzi, R.C. Griggs, J.R. Mendell, A.P. Hays, T.E. Bertorini, A. Pestronk, E. Bonilla & S. DiMauro: Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann. Neurol. 39, 789-795 (1996)
35. E.G. Gendek, J. Kedziora & H. Gendek-Kubiak: Can tissue transglutaminase be a marker of idiopathic inflammatory myopathies? Immunol. Lett. 97, 245-249 (2005)
36. S.E. Browne, A.C. Bowling, U. MacGarvey, M.J. Baik, S.C. Berger, M.M. Muqit, E.D. Bird & M.F. Beal: Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653 (1997)
37. M.F. Beal: Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6, 661-666 (1996)
38. G.M. Zainelli, C.A. Ross, J.C. Troncoso & N.A. Muma: Transglutaminase cross-links in intranuclear inclusions in Huntington disease. J. Neuropathol. Exp. Neurol. 62, 14-24 (2003)
39. S.-Y. Kim, L. Marekov, P. Bubber, S.E. Browne, I. Stavrovskaya, J. Lee, P.M. Steinert, J.P. Blass, M.F. Beal, G.E. Gibson & A.J.L. Cooper: Transglutaminase (TGase) Targets Mitochondrial Aconitase (Aco 2) in Rat Brain: A Possible Role of TGase in Mitochondrial Dysfunction Associated with Neurodegenerative Diseases. Neurochem Res. 30, 1245-1255 (2005)
40. S.-Y. Kim, P. Grant, J.-H. Lee, H.C. Pant & P.M. Steinert: Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J. Biol. Chem. 274, 30715-30721 (1999)
41. E. Junn, R.D. Ronchetti, M.M. Quezado, S.-Y. Kim & M.M. Mouradian: Tissue transglutaminase-induced aggregation of α-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 100, 2047-2052 (2003)
42. T. Furuno & M. Nakanishi: Neurotrophic factors increase TNF-α-induced nuclear translocation of NF-κB in rat PC12 cells. Neurosci. Lett. Oct. 17. [Epub ahead of print] (2005)
43. K. Heese, C. Hock & U. Otten: Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70, 699-707 (1998)
44. S.M. Laird, E.M. Tuckerman, B.A. Cork & T.C. Li: Expression of nuclear factor kappa B in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production. Mol. Hum. Reprod. 6, 34-40 (2000)